X0508 4 2024-02-21 0000009326 BALCHEM CORP BCPC 0001906436 Sestrick Michael Robert C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE NJ 07645 true SVP & Chief Technology Officer false Common Stock 2024-02-21 4 M 0 3900 76.89 A 10636 D Common Stock 2024-02-21 4 M 0 3500 74.57 A 14136 D Common Stock 2024-02-21 4 M 0 3700 84.09 A 17836 D Common Stock 2024-02-21 4 S 0 11100 153.2084 D 6736 D Stock Options (right to buy) 76.89 2024-02-21 4 M 0 3900 0 D 2027-04-18 Common Stock 3900 0 D Stock Options (right to buy) 74.57 2024-02-21 4 M 0 3500 0 D 2028-02-15 Common Stock 3500 0 D Stock Options (right to buy) 84.09 2024-02-21 4 M 0 3700 0 D 2029-02-13 Common Stock 3700 0 D Exercise of fully vested non-qualified stock options. This transaction was executed in multiple sales ranging from $152.7200 to $153.6600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Stock options that vested 20% on April 18, 2018, 40% on April 18, 2019, and 40% on April 18, 2020, and are exercisable. Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable. Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. /s/ Travis Larsen, Attorney in Fact for Michael Robert Sestrick 2024-02-23